Mechanism of androgen receptor activation and possible implications for chemoprevention trials

European Urology

Volumn 35, Issue 5-6, 1999, Pages 413-419

  Klocker, H ^a   Culig, Z ^a   Eder, I E ^a   Nessler Menardi, C ^a   Hobisch, A ^a   Putz, T ^a   Bartsch, G ^a   Peterziel, H ^a   Cato, A C B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Androgen receptor; Androgen withdrawal; Du 145; Ligand independent activation; LNCaP; PSA; Reporter gene; Transcriptional activity

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH FACTOR; HYDROXYFLUTAMIDE; METRIBOLONE; TRANSCRIPTION FACTOR AP 1;

CELL CULTURE; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION;

ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CLINICAL TRIALS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0032917958     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019918     Document Type: Conference Paper

References (28)